Annovis Bio, Inc. (ANVS)
USD 4.71
(-7.83%)
USD 4.71
(-7.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -39.96 Million | -17.31 Million | -9.13 Million | -3.97 Million | -476.54 Thousand | -558.6 Thousand |
| Net Income | -56.2 Million | -25.32 Million | -14.48 Million | -5.46 Million | -990.98 Thousand | -713.87 Thousand |
| Depreciation & Amortization | - | - | - | 129 Thousand | 1.19 Million | - |
| Deferred income taxes | - | - | - | -129 Thousand | -1.19 Million | - |
| Stock-based compensation | 4.62 Million | 9.15 Million | 4.69 Million | 1.86 Million | 8483.00 | 82.72 Thousand |
| Change in working capital | -228.59 Thousand | -1.13 Million | 657.34 Thousand | -400.71 Thousand | 421.52 Thousand | 72.53 Thousand |
| Other non-cash items | 11.83 Million | 5.87 Million | 4.35 Million | 27.02 Thousand | 84.42 Thousand | 85.41 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 17.34 Million | 4613.00 | 46.74 Million | 12.04 Million | 443.08 Thousand | 246.44 Thousand |
| Debt repayment | - | - | - | -12.03 Million | -521.69 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 17.34 Million | 4613.00 | 46.64 Million | 12.03 Million | -78.61 Thousand | 2800.00 |
| Other Financing Activities | 458.38 Million | 4.61 | 95.1 Thousand | 12.04 Million | 1.04 Million | 243.64 Thousand |
| Accounts receivables | - | - | - | 735.07 Thousand | -735.07 Thousand | - |
| Accounts payables | -2.66 Million | 3.27 Million | 346.21 Thousand | -695.66 Thousand | 969.09 Thousand | -2682.00 |
| Inventory | - | - | - | -735.07 Thousand | 735.07 Thousand | - |
| Other working capital | 2.43 Million | -4.41 Million | 311.12 Thousand | 294.94 Thousand | -547.56 Thousand | 75.21 Thousand |
| Cash at beginning of period | 28.37 Million | 45.68 Million | 8.07 Million | 1858.00 | 35.31 Thousand | 347.47 Thousand |
| Cash at end of period | 5.75 Million | 28.37 Million | 45.68 Million | 8.07 Million | 1858.00 | 35.31 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -22.62 Million | -17.3 Million | 37.61 Million | 8.07 Million | -33.45 Thousand | -312.16 Thousand |
| Free Cash Flow | -39.96 Million | -17.31 Million | -9.13 Million | -3.97 Million | -476.54 Thousand | -558.6 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.02 Million | -1.06 Million | -22.21 Million | -56.2 Million | -6.43 Million | -9.53 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.59 Million | 364.76 Thousand | 882.38 Thousand | 4.62 Million | 632.19 Thousand | 1.57 Million |
| Change in working capital | 2.81 Million | 368.12 Thousand | 128.83 Thousand | -228.59 Thousand | 4.71 Million | -1.64 Million |
| Other non-cash items | -457.56 Thousand | -9.14 Million | 11.83 Million | 11.83 Million | -5.34 Million | 4.55 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.23 Million | 4.41 Million | 8.76 Million | 17.34 Million | - | 8.57 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.23 Million | 4.41 Million | 8.76 Million | 17.34 Million | - | 8.57 Million |
| Other Financing Activities | - | 4415.00 | 8764.75 | 458.38 Million | - | 8572.19 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -712.17 Thousand | 2.81 Million | -633.56 Thousand | -2.66 Million | 753.52 Thousand | -2.98 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.52 Million | -2.44 Million | 762.39 Thousand | 2.43 Million | 3.96 Million | 1.33 Million |
| Cash at beginning of period | 3.13 Million | 5.75 Million | 6.35 Million | 28.37 Million | 15.72 Million | 16.75 Million |
| Cash at end of period | 3.99 Million | 3.13 Million | 5.75 Million | 5.75 Million | -6.43 Million | 15.72 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 860.79 Thousand | -2.61 Million | -600.22 Thousand | -22.62 Million | -22.15 Million | -1.03 Million |
| Free Cash Flow | -3.37 Million | -7.03 Million | -9.36 Million | -39.96 Million | -6.43 Million | -9.6 Million |
1450
SPKTF
GNFTF
5632
26490K
AIP